Editorial
Orthopedia homeobox protein (OTP) in the diagnostic and prognostic workup of pulmonary carcinoid tumors
Translational Lung Cancer Research
2023;
12
(1)
:1-5
.
(31 January 2023)
Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(1)
:6-10
.
(31 January 2023)
The path forward in early-stage lung cancer
Translational Lung Cancer Research
2023;
12
(1)
:11-13
.
(31 January 2023)
Original Article
Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients
Translational Lung Cancer Research
2023;
12
(1)
:14-26
.
(31 January 2023)
BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
Translational Lung Cancer Research
2023;
12
(1)
:27-41
.
(31 January 2023)
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells
Translational Lung Cancer Research
2023;
12
(1)
:42-65
.
(31 January 2023)
Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions
Translational Lung Cancer Research
2023;
12
(1)
:66-78
.
(31 January 2023)
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker
Translational Lung Cancer Research
2023;
12
(1)
:79-95
.
(31 January 2023)
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study
Translational Lung Cancer Research
2023;
12
(1)
:96-108
.
(31 January 2023)
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(1)
:109-126
.
(31 January 2023)
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV)
Translational Lung Cancer Research
2023;
12
(1)
:127-140
.
(31 January 2023)
Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
Translational Lung Cancer Research
2023;
12
(1)
:141-149
.
(31 January 2023)
A new preoperative localization of pulmonary nodules guided by mixed reality: a pilot study of an animal model
Translational Lung Cancer Research
2023;
12
(1)
:150-157
.
(31 January 2023)
Review Article
Narrative review: blood and tumor biomarker testing in non-small cell lung cancer without an oncogenic driver
Translational Lung Cancer Research
2023;
12
(1)
:158-167
.
(31 January 2023)
The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review
Translational Lung Cancer Research
2023;
12
(1)
:168-180
.
(31 January 2023)
